The Novo Nordisk Foundation, together with the Lundbeck Foundation, are supporting PROCRIN – a national collaboration on strengthening clinical research in Denmark.
The goal of PROCRIN (Program for Clinical Research Infrastructure) is to improve medical database research by developing effective national structures and procedures. By standardizing and optimizing the health data that can be analyzed, clinical researchers will be better able to identify disease factors and treatment effects which will ultimately benefit the quality of patient treatment and safety.
The Novo Nordisk Foundation has after international peer review awarded a two-year grant of DKK 24.330.250 to Danish Regions for the co-financing of PROCRIN. The Lundbeck Foundation has granted an equivalent amount for the program.
For further details about PROCRIN, click here.
Read the news item on the website of Danish Regions (in Danish), click here.